AlphAIAlphAI — Financial news for AI agents
investing.comOCT 222 min read$ROL

UBS maintains Rollins stock rating at Neutral on growth concerns

UBS kept Rollins (ROL) at Neutral with a $36.00 target after Q3 results. Organic growth was 4.4%, missing estimates. Shares fell 39% in six months. Q3 revenue was $1.09B, EPS $0.34, both below expectations. Rollins cut full-year organic growth outlook to 4-6%.

Original reporting
investing.com
Published Oct 22, 2026, 2:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 2:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$ROL
Bearish
high confidence
Mentioned
$ROL
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ROLBearishLow
01

Why it matters

The earnings miss and neutral rating could trigger short‑term selling, but the company’s cash generation and dividend yield may support longer‑term investors.

02

Market read

Rollins’ Q3 miss and unchanged rating suggest limited upside; traders may watch for further guidance or strategic updates.

03

What to watch

Potential upside from upcoming residential acquisition initiatives and AI‑driven marketing improvements.

Relevance 7/10Novelty 6/10Timing: post‑market today

Background

Rollins is a $16.8 bn pest‑control leader; its Q3 revenue was $1.09 bn with EPS $0.34, both slightly below forecasts.

Company-level read

Ticker impact

$ROLBearishHigh confidence
Context

UBS reiterated a Neutral rating on Rollins after Q3 results missed growth estimates, noting a 39% six‑month decline.

Expected impact

likely downward pressure as investors price in the growth miss and neutral rating

Evidence & confidence

The earnings miss and unchanged neutral stance suggest limited upside and potential further sell‑off.

Market effects

Sector

Pest‑control sector may see broader scrutiny on growth metrics.

Regional

U.S. equities may experience modest pullback in consumer‑services stocks.

Global

Limited to U.S. market; no global ripple effect.

Counterpoint

What could challenge this read

The stock may be undervalued given its cash flow stability and long‑term contracts.

Key entities

  • Analyst
    UBS

    Provided the Neutral rating and $36 price target.

  • Analyst
    Joshua Chan

    UBS analyst authoring the rating note.

Read at source← All news

Related articles

OCT 23
$ROLMed

Canaccord lowers Rollins stock price target on weak Q3 results

Canaccord reduced its price target for Rollins Inc. (NYSE: ROL) to $33 from $36, citing weak Q3 results. The pest control company missed sales and EBITDA expectations, with residential and commercial segments underperforming. Margins were pressured by higher costs. Rollins reported Q3 adjusted earnings of $0.34 per share on revenue of $1.09 billion, both below forecasts. The company lowered its full-year organic growth outlook to 4-6%.

investing.com2 min
OCT 22
$ROLHigh

Rollins Inc (ROL) Q3 2026 Earnings Call Highlights: Organic Growth Misses as AI Search

Rollins Inc (ROL) reported Q3 2026 organic growth of 4.4%, missing expectations due to residential customer acquisition pressure. AI-driven search disrupted lead flow, causing gross margin to decrease 90 bps YoY and adjusted EBITDA to fall 0.7% YoY. Full-year organic growth guidance was lowered to 4%-6% from 6%. CEO Jerry Gahlhoff noted some improvement in September but cautioned against sustained trends. The company is adjusting strategies to adapt to the changing search landscape.

finance.yahoo.com2 min
OCT 22
$ROLHighAI 8/10

What Rollins (ROL) Said on Its Q3 Earnings Call

Rollins (ROL) reported Q3 gross margin of 53.5%, down 0.9% YoY, due to higher insurance, fleet, and fuel costs. GAAP net income was $158M ($0.33/share), down 2.9% YoY. The company lowered its 2026 organic revenue growth outlook to 4-6% from 6%. Rollins generated $235M in free cash flow, completed seven acquisitions, and increased its dividend by 10%. Management outlined digital strategy priorities for residential customer acquisition.

finance.yahoo.com2 min
OCT 22
$ROLMed

Rollins (ROL) Q3 2026 Earnings Call Transcript

Rollins (ROL) reported Q3 2026 earnings with total revenue up 6.2% and organic growth at 4.4%, below expectations. Residential growth was 4.9%, commercial 7.7%, and termite/ancillary 6.5%. Challenges included slower customer acquisition and staffing constraints. The company is adapting its digital customer acquisition strategy to improve visibility and lead conversion.

finance.yahoo.com3 min